Advertisement
Canada markets closed

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7257
    -0.0007 (-0.09%)
     

  • CRUDE OIL

    83.94
    +1.21 (+1.46%)
     

  • Bitcoin CAD

    85,706.24
    +1,065.43 (+1.26%)
     

  • CMC Crypto 200

    1,297.54
    +412.00 (+46.53%)
     

  • GOLD FUTURES

    2,401.80
    +3.80 (+0.16%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     

  • NASDAQ futures

    17,391.75
    -155.50 (-0.89%)
     

  • VOLATILITY

    18.00
    -0.21 (-1.15%)
     

  • FTSE

    7,877.05
    +29.06 (+0.37%)
     

  • NIKKEI 225

    37,237.67
    -842.03 (-2.21%)
     

  • CAD/EUR

    0.6822
    +0.0001 (+0.01%)
     

NuVasive (NUVA) in Focus: Stock Moves 8.4% Higher

Zacks Equity Research
Updated

NuVasive, Inc. NUVA  was a big mover last session, as the company saw its shares rise over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $50.58–$56.95 in the past one-month time frame, witnessed a sharp increase yesterday.

The move came after the company reported better-than-expected third-quarter results and announced a major stock repurchase program.

The Zacks Consensus Estimate for the current quarter has moved higher over the past one month, suggesting that more solid trading could be ahead for NuVasive. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road. 

NuVasive currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is positive.

ADVERTISEMENT

NuVasive, Inc. Price and Consensus

NuVasive, Inc. Price and Consensus | NuVasive, Inc. Quote

A better ranked stock in the Medical - Products industry is Terumo Corp. TRUMY which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is NUVA going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
NuVasive, Inc. (NUVA) : Free Stock Analysis Report
 
Terumo Corp. (TRUMY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.